Clinical trial registry record

Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase 2 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated August 9, 2018.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT02345031
Last registry update
August 9, 2018
Status
Completed
Phase
Phase 2
Sponsor
Autifony Therapeutics Limited
Enrollment
78
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 2
Study design
RANDOMIZED · PARALLEL · TREATMENT · QUADRUPLE
Evidence population
Human clinical study registration
Participants
78
Population
ALL · 50 Years to 89 Years
Duration
2015-01-01 to 2016-06-01
Intervention
AUT00063; Placebo
Comparator
AUT00063 (600 mg capsules); (AUT00063 placebo capsules)
Outcomes measured
Change in Hearing Loss After 4 Weeks of Treatment — 28 days; Analysis of Change From Baseline in Adaptive Test of Temporal Resolution (ATTR) on End-Point Visit Day 28 — 28 days; To Further Investigate the Safety and Tolerability Profile of Repeat Administration of AUT00063 by Assessing Vital Sign…; Pharmacokinetic of AUT00063, Plasma Levels — 28 Days
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 2A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Hearing ageing · 100%Title contains controlled term: age-related hearing loss. Abstract contains controlled term: age-related hearing loss. Source terminology contains: age-related hearing loss. Title supplies longevity context: age-related. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

hearing aging
Open primary sourceExport JSON